Oxford University Innovation Q1 2021 Update
37 new companies in the past 12 months, Nanopore's IPO on the horizon, and £400m+ investment in Q1 alone - get caught up with the latest from Oxford University Innovation.
Cancer vaccines are goal of new Oxford University company
OxVax, a spinout from Oxford University, has formed with the objective of producing vaccines for cancer.
Singula Bio provides new hope for cancer with diverse, individualised therapies
The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer
© Oxford University Innovation